You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PHENAZINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Phenazine, and when can generic versions of Phenazine launch?

Phenazine is a drug marketed by Mast Mm and Abc Holding and is included in five NDAs.

The generic ingredient in PHENAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phenazine

A generic version of PHENAZINE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENAZINE?
  • What are the global sales for PHENAZINE?
  • What is Average Wholesale Price for PHENAZINE?
Summary for PHENAZINE
Drug patent expirations by year for PHENAZINE
Recent Clinical Trials for PHENAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Saudi German Hospital - MadinahPhase 2/Phase 3
M.D. Anderson Cancer CenterN/A

See all PHENAZINE clinical trials

US Patents and Regulatory Information for PHENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mast Mm PHENAZINE phendimetrazine tartrate CAPSULE;ORAL 086523-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mast Mm PHENAZINE phendimetrazine tartrate TABLET;ORAL 087305-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mast Mm PHENAZINE phendimetrazine tartrate CAPSULE;ORAL 086524-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mast Mm PHENAZINE phendimetrazine tartrate CAPSULE;ORAL 086525-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.